Assignee
MACREGEN INC
US·2 granted patents·4 pending applications·8 citations·filing 2017–2020
Top patents by PatentIndex Score
6 records- 0183US10426817B2Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimeticsMACREGEN INC·Filed 2017·Granted Oct 1, 2019·5 cites·24 claims
- 0277US10905770B2Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseasesMACREGEN INC·Filed 2018·Granted Feb 2, 2021·3 cites·19 claims
- 0357US2021138034A1Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimeticsMACREGEN INC·Filed 2020·Application pending·0 cites
- 0455US2020069770A1Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimeticsMACREGEN INC·Filed 2019·Application pending·0 cites
- 0549US2021085797A1Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseasesMACREGEN INC·Filed 2020·Application pending·0 cites
- 0638US2018296525A1Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agentsMACREGEN INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MACREGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →